[HTML][HTML] MPTP-induced mouse model of Parkinson's disease: A promising direction for therapeutic strategies

M Mustapha, CNM Taib - Bosnian journal of basic medical …, 2021 - ncbi.nlm.nih.gov
Among the popular animal models of Parkinson's disease (PD) commonly used in research
are those that employ neurotoxins, especially 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine …

Neurochemical findings in the MPTP model of Parkinson's disease

N Schmidt, B Ferger - Journal of neural transmission, 2001 - Springer
Animal models are a very important approach to study the pathogenesis and therapeutic
intervention strategies of human diseases. Since many human disorders do not arise …

MPTP mouse models of Parkinson's disease: an update

GE Meredith, DJ Rademacher - Journal of Parkinson's …, 2011 - content.iospress.com
Among the most widely used models of Parkinson's disease (PD) are those that employ
toxins, especially 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP). Depending on the …

[HTML][HTML] Dynamic changes in the nigrostriatal pathway in the MPTP mouse model of Parkinson's disease

D Huang, J Xu, J Wang, J Tong, X Bai, H Li… - Parkinson's …, 2017 - hindawi.com
The characteristic brain pathology and motor and nonmotor symptoms of Parkinson's
disease (PD) are well established. However, the details regarding the causes of the disease …

Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) in the mouse

RE Heikkila, BA Sieber, L Manzino… - Molecular and Chemical …, 1989 - Springer
Conclusion The discovery that a rather simple chemical substance can produce such a
highly selective neuronal degeneration in the substantia nigra, the brain area most affected …

Chemically induced models of Parkinson's disease

T Thirugnanam, K Santhakumar - … and Physiology Part C: Toxicology & …, 2022 - Elsevier
Environmental toxins are harmful substances detrimental to humans. Constant exposure to
these fatal neurotoxins can cause various neurodegenerative disorders. Although …

Progressive dopaminergic degeneration in the chronic MPTPp mouse model of Parkinson's disease

N Schintu, L Frau, M Ibba, A Garau, E Carboni… - Neurotoxicity …, 2009 - Springer
Parkinson's disease (PD) is characterized by a progressive degeneration of dopamine (DA)
neurons and gradual worsening of motor symptoms. The investigation of progressive …

MPTP as a mitochondrial neurotoxic model of Parkinson's disease

S Przedborski, K Tieu, C Perier, M Vila - Journal of bioenergetics and …, 2004 - Springer
Methy-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) is a potent neurotoxin extensively used
to model Parkinson's disease (PD). A cascade of deleterous events, in which mitochondria …

The MPTP model of Parkinson's disease

RJ Smeyne, V Jackson-Lewis - Molecular brain research, 2005 - Elsevier
The biochemical and cellular changes that occur following administration of 1-methyl-4-
phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) are remarkably similar to that seen in idiopathic …

Mechanisms of MPTP toxicity and their implications for therapy of Parkinson's disease.

Y Watanabe, T Himeda, T Araki - Medical science monitor, 2005 - medscimonit.com
Parkinson's disease is one of the major neurodegenerative disorders. This disease is mainly
characterized by tremor, bradykinesia, rigidity and postural instability that results primarily …